Author

Chonlaphat Sukasem

Mahidol University - Cited by 3,828 - Pharmacogenomics

Biography

Chonlaphat Sukasem currently Head, Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University Chief, Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center, Ramathibodi Hospital Project Director, Pharmacogenomics for Autistic Child, Khon Poom Foundation, TheProject in Her Royal Highness Princess Ubonratana Rajakanya Siriwatana Bhanawadee
Title
Cited by
Year
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
P Satapornpong, J Pratoomwun, P Rerknimitr, J Klaewsongkram, ...Frontiers in immunology 12, 661135, 2021202
24
2021
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
C Kloypan, N Koomdee, P Satapornpong, T Tempark, M Biswas, ...Pharmaceuticals 14 (11), 1077, 212
20
2021
Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
T Jantararoungtong, T Tempark, N Koomdee, S Medhasi, C SukasemExpert Opinion on Drug Metabolism & Toxicology 17 (9), 1049-1064, 2021202
15
2021
Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies
M Biswas, N Sawajan, T Rungrotmongkol, K Sanachai, M Ershadian, ...Frontiers in pharmacology 13, 835136, 2022202
14
2022
Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis
C Sukasem, S Sririttha, C Chaichan, T Nakkrut, P Satapornpong, ...The Pharmacogenomics Journal 21 (6), 682-690, 2021202
13
2021
HLA Class-II‒Restricted CD8+ T cells contribute to the promiscuous immune response in dapsone-hypersensitive patients
Q Zhao, M Almutairi, A Tailor, A Lister, N Harper, J Line, X Meng, ...Journal of Investigative Dermatology 141 (10), 2412-2425. e2, 2021202
13
2021
Pharmacogenomics research and its clinical implementation in Thailand: lessons learned from the resource-limited settings
C Sukasem, T Jantararoungtong, N KoomdeeDrug Metabolism and Pharmacokinetics 39, 100399, 2021202
13
2021
Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
R Sukprasong, S Chuwongwattana, N Koomdee, T Jantararoungtong, ...Scientific Reports 11 (1), 343, 2021202
12
2021
Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
J Pratoomwun, P Thomson, K Jaruthamsophon, R Tiyasirichokchai, ...Frontiers in Immunology 12, 658593, 2021202
11
2021
Resolving discordant CYP2D6 genotyping results in Thai subjects: platform limitations and novel haplotypes
Y Hongkaew, WY Wang, R Gaedigk, C Sukasem, A GaedigkPharmacogenomics 22 (), 52-541, 2021202
9
2021
8
2022
Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population
S John, K Balakrishnan, C Sukasem, TCV Anand, B Canyuk, ...Journal of personalized medicine 11 (), 737, 2021202
8
2021
HLA Allele–Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction
K Jaruthamsophon, PJ Thomson, C Sukasem, DJ Naisbitt, M PirmohamedAnnual Review of Pharmacology and Toxicology 62, 509-529, 2022202
8
2022
TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
T Jantararoungtong, S Wiwattanakul, R Tiyasirichokchai, S Prommas, ...Journal of Personalized Medicine 11 (8), 83, 2021202
7
2021
Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
M Biswas, M Ershadian, J Shobana, AH Nguyen, C SukasemClinical and Translational Science 15 (8), 1887-1905, 2022202
6
2022
Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions
Genetic Determinants in HLA and Cytochrome P40 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse ReactionsAF Ahmed, C Sukasem, MA Sabbah, NF Musa, DA Mohamed Noor, ...Journal of Personalized Medicine 11 (), 383, 2021202
5
2021
Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
C Atasilp, M Biswas, P Jinda, N Nuntharadthanaphong, J Rachanakul, ...Clinical and Translational Science 15 (7), 1613-1633, 2022202
4
2022
Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
M Chamnanphon, R Sukprasong, A Gaedigk, W Manosuthi, ...Pharmacogenomics and Personalized Medicine, 915-926, 2021202
3
2021
Simplified and rapid determination of primaquine and 5, 6-orthoquinone primaquine by UHPLC-MS/MS: its application to a pharmacokinetic study
W Pookmanee, S Thongthip, J Tankanitlert, M Mungthin, C Sukasem, ...Molecules 26 (14), 457, 2021202
3
2021